Iland, H. J. (2025) “Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the CONS”, Haematologica. Pavia, Italy, 110(7), pp. 1459-1465. doi: 10.3324/haematol.2025.287418.